| abstract |
REFERS TO A COMBINATION OF SUBSTANCES THAT INCLUDES: a) FROM 0.001mg-15mg OF AN O2 AGONIST SUCH AS A PREFERENCE IMIDAZOL COMPOUND FROM 0.5mg TO 10mg OF AZEPEXOL, BRIMONIDINE, FROM 0.01mg TO 1mg OF CLONIDINE, DEXMEDETOMIDINE FROM 0.05mg TO 5mg OF LOFEXIDINE, MEDETOMIDINE, MOXOMIDINE, FROM 0.05mg TO 5mg OF RILMENIDINE, TALIPEXOL, FROM 0.05mg TO 7mg OF THAMENIDINE, TIZANIDINE; b) A NEUROPSYCHOPHARM THAT REDUCES THE SYMPTOMS OF LOOSE LEGS SYNDROME SUCH AS i) DOPAMINE AGONISTS AGENTS (FROM 1.25mg TO 20mg OF BROMOCRIPTINE, FROM 0.05mg TO 5mg OF CABERGOLIN, FROM 5mg TO 60mg OF O-DIHYDROPTHINE , FROM 0.1mg TO 5mg OF LISURIDE, FROM 0.05mg TO 1mg OF PERGOLIDE, PIRIPEDIL, FROM 0.01mg TO 5mg OF PRAMIPEXOL, FROM 0.2mg TO 10mg OF ROPINIROL, S - (-) - 2- (N- PROPYL-N-2-THENYL-ETHYL-AMINO) -5-HYDROXY-TETRALINE, (R) -5,6-DIHYDRO-5- (METHYLAMINE) -4H-IMIDAZO (4,5,1-ij) -QUINOLINE- 2 (1H) -ONE, BENZODIAZEPINES (CLONAZEPAM, BROTIZOLAM, TEMAZEPAN, NITRAZEPAM, OXAZEPAM) OR A COMBINATION OF 10mg TO 500mg OF L-DOPA AND FROM 1mg TO 100mg OF AN INHIBITING AGENT OF BUILDING DECARBOXYLASE, OR CARBOXYLODOPIDAL; FROM 10mg TO 100mg OF CODEINE, DEXTROPROPOXIFEN, FROM 10mg TO 100mg OF DIHYDROCODEINE, FENTANIL, HYDROMORPHONE, LEVOMETADONE, MORPHINE, FROM 4.5mg TO 20mg OF OXYCODONE, PETIDINE, FROM 65mg TO 300mg OF PROPOXYLENTHYLENE, SUPHYLODENE, SUPHAMETHYLENE OTHERS) |